Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study

Clinical Microbiology and Infection

Volumn 20, Issue 12, 2014, Pages 1357-1362

  Giannella, M ^a   Trecarichi, E M ^b   De Rosa, F G ^c   Del Bono, V ^d   Bassetti, M ^e   Lewis, R E ^a   Losito, A R ^b   Corcione, S ^c   Saffioti, C ^d   Bartoletti, M ^a   Maiuro, G ^b   Cardellino, C S ^c   Tedeschi, S ^a   Cauda, R ^b   Viscoli, C ^d   Viale, P ^a   Tumbarello, M ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e S Maria Hospital   (Italy)

Author keywords

Bloodstream infection; Carbapenem resistance; Colonization status; Rectal carriers

Indexed keywords

KLEBSIELLA PNEUMONIAE;

ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; CASE CONTROL STUDY; CLINICAL TRIAL; DRUG EFFECTS; FEMALE; HETEROZYGOTE; HUMAN; INCIDENCE; ISOLATION AND PURIFICATION; ITALY; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; RECTUM; RISK FACTOR; TEACHING HOSPITAL; TERTIARY CARE CENTER; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CARBAPENEMS; CARRIER STATE; CASE-CONTROL STUDIES; FEMALE; HOSPITALS, TEACHING; HUMANS; INCIDENCE; ITALY; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECTUM; RISK FACTORS; TERTIARY CARE CENTERS; YOUNG ADULT;

EID: 84920261073     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12747     Document Type: Article

References (16)

1. Viale P, Giannella M, Lewis R, Trecarichi EM, Petrosillo N, Tumbarello M. Predictors of mortality in multidrug-resistant klebsiella pneumoniae bloodstream infections. Expert Rev Anti Infect Ther 2013; 11: 1053-1063.
2. Capone A, Giannella M, Fortini D et al. High rate of colistin resistance among patients with carbapenem-resistant klebsiella pneumoniae infection accounts for an excess of mortality. Clin Microbiol Infect 2013; 19: E23-E30.
3. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008; 29: 1099-1106.
4. Nguyen M, Eschenauer GA, Bryan M et al. Carbapenem-resistant klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes. Diagn Microbiol Infect Dis 2010; 67: 180-184.
5. Zarkotou O, Pournaras S, Tselioti P et al. Predictors of mortality in patients with bloodstream infections caused by kpc-producing klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect 2011; 17: 1798-1803.
6. Qureshi ZA, Paterson DL, Potoski BA et al. Treatment outcome of bacteremia due to kpc-producing klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother 2012; 56: 2108-2113.
7. Tumbarello M, Viale P, Viscoli C et al. Predictors of mortality in bloodstream infections caused by kpc-producing klebsiella pneumoniae: importance of combination therapy. Clin Infect Dis 2012; 55: 943-950.
8. Lubbert C, Becker-Rux D, Rodloff AC et al. Colonization of liver transplant recipients with kpc-producing klebsiella pneumoniae is associated with high infection rates and excess mortality: a case-control analysis. Infection 2014; 42: 309-316.
9. Tumbarello M, Trecarichi E, Tumietto F et al. Predictive models for identification of hospitalized patients harboring kpc-producing klebsiella pneumoniae. Antimicrob Agents Chemother 2014; 58: 3514-3520.
10. Borer A, Saidel-Odes L, Eskira S et al. Risk factors for developing clinical infection with carbapenem-resistant klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant k pneumoniae. Am J Infect Control 2012; 40: 421-425.
11. Schechner V, Kotlovsky T, Kazma M et al. Asymptomatic rectal carriage of blakpc producing carbapenem-resistant enterobacteriaceae: who is prone to become clinically infected? Clin Microbiol Infect 2013; 19: 451-456.
12. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
13. Institute CaLS. Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. CLSI document M100-S21 Wayne, PA: Institute CaLS, 2011.
14. Rasheed J, Cockerill F, Tenover F, eds. Detection and characterization of antimicrobial resistance genes in pathogenic bacteria, 9th edn. Washington, DC: ASM Press, 2007.
15. Royston P, Moons KG, Altman DG, Vergouwe Y. Prognosis and prognostic research: developing a prognostic model. BMJ 2009; 338: b604.
16. Akova M, Daikos GL, Tzouvelekis L, Carmeli Y. Interventional strategies and current clinical experience with carbapenemase-producing gram-negative bacteria. Clin Microbiol Infect 2012; 18: 439-448.